These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 30621636)

  • 1. A systematic literature review of the clinical efficacy of repetitive transcranial magnetic stimulation (rTMS) in non-treatment resistant patients with major depressive disorder.
    Voigt J; Carpenter L; Leuchter A
    BMC Psychiatry; 2019 Jan; 19(1):13. PubMed ID: 30621636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of repetitive transcranial magnetic stimulation on the Hamilton Depression Rating Scale-17 criterion in patients with major depressive disorder without psychotic features: a systematic review and meta-analysis of intervention studies.
    Hassanzadeh E; Moradi G; Arasteh M; Moradi Y
    BMC Psychol; 2024 Sep; 12(1):480. PubMed ID: 39256851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repetitive Transcranial Magnetic Stimulation for the Acute Treatment of Major Depressive Episodes: A Systematic Review With Network Meta-analysis.
    Brunoni AR; Chaimani A; Moffa AH; Razza LB; Gattaz WF; Daskalakis ZJ; Carvalho AF
    JAMA Psychiatry; 2017 Feb; 74(2):143-152. PubMed ID: 28030740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of repetitive transcranial magnetic stimulation (rTMS) adjunctive therapy for major depressive disorder (MDD) after two antidepressant treatment failures: meta-analysis of randomized sham-controlled trials.
    Vida RG; Sághy E; Bella R; Kovács S; Erdősi D; Józwiak-Hagymásy J; Zemplényi A; Tényi T; Osváth P; Voros V
    BMC Psychiatry; 2023 Jul; 23(1):545. PubMed ID: 37501135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and acceptability of accelerated repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant major depressive disorder: an open label trial.
    McGirr A; Van den Eynde F; Tovar-Perdomo S; Fleck MP; Berlim MT
    J Affect Disord; 2015 Mar; 173():216-20. PubMed ID: 25462419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Durability of the antidepressant effect of the high-frequency repetitive transcranial magnetic stimulation (rTMS) In the absence of maintenance treatment in major depression: a systematic review and meta-analysis of 16 double-blind, randomized, sham-controlled trials.
    Kedzior KK; Reitz SK; Azorina V; Loo C
    Depress Anxiety; 2015 Mar; 32(3):193-203. PubMed ID: 25683231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy and acceptability of non-surgical brain stimulation for the acute treatment of major depressive episodes in adults: systematic review and network meta-analysis.
    Mutz J; Vipulananthan V; Carter B; Hurlemann R; Fu CHY; Young AH
    BMJ; 2019 Mar; 364():l1079. PubMed ID: 30917990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Health-related quality of life assessment in depression after low-frequency transcranial magnetic stimulation].
    Dumas R; Boyer L; Richieri R; Guedj E; Auquier P; Lançon C
    Encephale; 2014 Feb; 40(1):74-80. PubMed ID: 24091070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-frequency repetitive transcranial magnetic stimulation over the left DLPFC for major depression: Session-dependent efficacy: A meta-analysis.
    Teng S; Guo Z; Peng H; Xing G; Chen H; He B; McClure MA; Mu Q
    Eur Psychiatry; 2017 Mar; 41():75-84. PubMed ID: 28049085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: a systematic review and meta-analysis.
    Ren J; Li H; Palaniyappan L; Liu H; Wang J; Li C; Rossini PM
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jun; 51():181-9. PubMed ID: 24556538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is rTMS effective for anxiety symptoms in major depressive disorder? An efficacy analysis comparing left-sided high-frequency, right-sided low-frequency, and sequential bilateral rTMS protocols.
    Chen L; Hudaib AR; Hoy KE; Fitzgerald PB
    Depress Anxiety; 2019 Aug; 36(8):723-731. PubMed ID: 30958907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-Effectiveness of Repetitive Transcranial Magnetic Stimulation versus Antidepressant Therapy for Treatment-Resistant Depression.
    Nguyen KH; Gordon LG
    Value Health; 2015 Jul; 18(5):597-604. PubMed ID: 26297087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review of the safety and effectiveness of repetitive transcranial magnetic stimulation in the treatment of peripartum depression.
    Cole J; Bright K; Gagnon L; McGirr A
    J Psychiatr Res; 2019 Aug; 115():142-150. PubMed ID: 31129438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-frequency repetitive transcranial magnetic stimulation accelerates and enhances the clinical response to antidepressants in major depression: a meta-analysis of randomized, double-blind, and sham-controlled trials.
    Berlim MT; Van den Eynde F; Daskalakis ZJ
    J Clin Psychiatry; 2013 Feb; 74(2):e122-9. PubMed ID: 23473357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rational insurance coverage policy for repetitive transcranial magnetic stimulation for major depression.
    Reti IM
    J ECT; 2013 Jun; 29(2):e27-8. PubMed ID: 23446702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of intermittent Theta Burst Stimulation (iTBS) and 10-Hz high-frequency repetitive transcranial magnetic stimulation (rTMS) in treatment-resistant unipolar depression: study protocol for a randomised controlled trial.
    Bulteau S; Sébille V; Fayet G; Thomas-Ollivier V; Deschamps T; Bonnin-Rivalland A; Laforgue E; Pichot A; Valrivière P; Auffray-Calvier E; Fortin J; Péréon Y; Vanelle JM; Sauvaget A
    Trials; 2017 Jan; 18(1):17. PubMed ID: 28086851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review and meta-analysis on placebo response to repetitive transcranial magnetic stimulation for depression trials.
    Razza LB; Moffa AH; Moreno ML; Carvalho AF; Padberg F; Fregni F; Brunoni AR
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():105-113. PubMed ID: 29111404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential predictors of depressive relapse following repetitive Transcranial Magnetic Stimulation: A systematic review.
    Miljevic A; Bailey NW; Herring SE; Fitzgerald PB
    J Affect Disord; 2019 Sep; 256():317-323. PubMed ID: 31201982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychotherapy and psychopharmacology utilization following repetitive transcranial magnetic stimulation (rTMS) in patients with major depressive disorder.
    Needs P; Mote SD; Manocchia M; King JD; Szuba DD; Lustig SL; Shah VN
    Psychiatry Res; 2019 Aug; 278():51-55. PubMed ID: 31146141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost effectiveness analysis comparing repetitive transcranial magnetic stimulation to antidepressant medications after a first treatment failure for major depressive disorder in newly diagnosed patients - A lifetime analysis.
    Voigt J; Carpenter L; Leuchter A
    PLoS One; 2017; 12(10):e0186950. PubMed ID: 29073256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.